Vancouver, British Columbia
(FSCwire) - EVITRADE Health Systems Corp. (CSE:EVA, OTCQB: AXHLF)
(the “Company”) announces that at the Annual General and Special
Meeting all resolutions were approved unanimously. In
addition, under advisement from our newly elected board member, Mr.
CK Cheung, (an Executive Director with the China Investment Trust),
the board is pleased to announce that a licensed broker-dealer in
Canada and USA, has been selected as a financial advisor to the
Company. This broker-dealer has participated in multiple bought
deal financings and have listed and up-listed companies in numerous
sectors. Management believes that the divestiture of the
C&C subsidiary will benefit from the broker-dealer’s
involvement and management believes there will be a good fit for
working with our remaining subsidiaries, including our main digital
healthcare company. Details are to be released upon receiving
appropriate clearances.
For the Industrial Hemp and
Cannabis Farm, CBD Plant Oils Extraction Company and the C&C
subsidiary merger (to be finalized under comprehensive definitive
agreement(s)); it is expected that all shareholders holding shares
on the share record distribution date for that subsidiary, will
receive shares on a 1:1 basis with no consolidation. Under
the approved plan of arrangement each subsidiary can have different
share distribution ratios of up to a 20:1 consolidation effect,
different share record distribution dates, and different effective
dates; all which shall be announced in the near future.
Contact: Ron Ozols, Director
EVITRADE Health Systems
Corporation
(formerly Auxellence Health
Corporation)
Twitter: @evitradehealth or
https://twitter.com/evitradehealth
Email: info@auxellence.com
Website: http://www.auxellence.com
CSE Micro-site:
http://thecse.com/en/listings/technology/evitrade-health-systems-corp
US OTC Markets:
http://www.otcmarkets.com/stock/AXHLF/news
About EVITRADE Health
(CSE: EVA, OTCQB: AXHLF)
EVITRADE (formerly Auxellence
Health Corp.), was founded in 2013 to provide online “digital
healthcare” services for resolving common health problems. The
current markets are weight-loss, high blood pressure, high blood
glucose and heart arrhythmia.
Disclaimers – Forward Looking Statements
